DDF->affect->human:
	Oxymatrine ameliorates white matter injury by modulating gut microbiota after intracerebral hemorrhage in mice.
	Oxymatrine ameliorates white matter injury by modulating gut microbiota after intracerebral hemorrhage in mice.
	Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
	Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
	Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease.
	HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis.
	HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis.

DDF->influence->DDF:
	Oxymatrine ameliorates white matter injury by modulating gut microbiota after intracerebral hemorrhage in mice.
	Microbiome changes: an indicator of Parkinson's disease?
	Sleep deprivation-induced anxiety-like behaviors are associated with alterations in the gut microbiota and metabolites.
	Disrupted diurnal oscillations of the gut microbiota in patients with alcohol dependence.
	Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks.
	Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks.
	Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.
	Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.
	Infections, antibiotic treatment and the Microbiome in relation to schizophrenia.
	Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study.
	The gut microbiota metabolite butyrate mitigates MPTP/MPP<sup>+</sup> -induced Parkinson's disease by inhibiting the JAK2/STAT3 signaling pathway.
	Diet-gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders.
	Diet-gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders.
	Research Progress on the Relationship between Parkinson's Disease and REM Sleep Behavior Disorder.

chemical->change effect->DDF:
	A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS).
	Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling.
	Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut-microbiota-brain axis.
	Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice.
	Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
	Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
	Ginsenoside Rk3 Regulates Tryptophan Metabolism along the Brain-Gut Axis by Targeting Tryptophan Hydroxylase and Remodeling the Intestinal Microenvironment to Alleviate Depressive-Like Behavior in Mice.
	Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
	The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
	N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
	N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
	N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	<i>Gastrodia elata</i> polysaccharide alleviates Parkinson's disease <i>via</i> inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota.
	Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice <i>via</i> regulating oxidative damage, inflammation, and gut microbiota disorder.
	Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice <i>via</i> regulating oxidative damage, inflammation, and gut microbiota disorder.
	Sika Deer Velvet Antler Peptide Exerts Neuroprotective Effect in a Parkinson's Disease Model via Regulating Oxidative Damage and Gut Microbiota.
	Melatonin mitigates manganese-induced neural damage via modulation of gut microbiota-metabolism in mice.

dietary supplement->change effect->DDF:
	A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS).
	Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling.
	Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling.
	Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A <i>Post Hoc</i> Analysis of a Randomized Clinical Trial.
	Microbial Therapeutics in Neurocognitive and Psychiatric Disorders.
	Komagataella pastoris KM71H Mitigates Depressive-Like Phenotype, Preserving Intestinal Barrier Integrity and Modulating the Gut Microbiota in Mice.
	The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult Cancer survivors; study protocol.
	Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson's Disease Rats.
	Effects of sulforaphane on cognitive function in patients with frontal brain damage: study protocol for a randomised controlled trial.
	Effect of Ginger Root Powder on Gastrointestinal Bacteria Composition, Gastrointestinal Symptoms, Mental Health, Fatigue, and Quality of Life: A Double-Blind Placebo-Controlled Trial.
	Effect of <i>Lacticaseibacillus paracasei</i> strain Shirota supplementation on clinical responses and gut microbiome in Parkinson's disease.
	Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson's disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
	Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's disease: results from an open label single-arm study.
	Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
	Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.

human->used by->statistical technique:
	A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS).
	Obesity and mental health improvement following nutritional education focusing on gut microbiota composition in Japanese women: a randomised controlled trial.
	Alterations of gut microbiota are associated with blood pressure: a cross-sectional clinical trial in Northwestern China.
	Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms.
	Gut microbiota alterations in response to sleep length among African-origin adults.
	Unravelling the mechanisms of underweight in Parkinson's disease by investigating into the role of gut microbiome.

gene->affect->DDF:
	EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling.
	Diet, Gut Microbiome, and Cognitive Decline.
	The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson's disease.

gene->located in->animal:
	EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling.
	The gut microbiota influences skeletal muscle mass and function in mice.
	The gut microbiota influences skeletal muscle mass and function in mice.
	Heat-killed Enterococcus fecalis (EC-12) supplement alters the expression of neurotransmitter receptor genes in the prefrontal cortex and alleviates anxiety-like behavior in mice.
	Neuroprotective Effects of <i>Lactobacillus plantarum</i> PS128 in a Mouse Model of Parkinson's Disease: The Role of Gut Microbiota and MicroRNAs.

human->target->human:
	Maternal weight, gut microbiota, and the association with early childhood behavior: the PREOBE follow-up study.
	Current iron therapy in the light of regulation, intestinal microbiome, and toxicity: are we prescribing too much iron?
	Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
	Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
	Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
	Gut microbiota of Parkinson's disease in an appendectomy cohort: a preliminary study.
	Microbiota-Gut-Brain Axis and Antidepressant Treatment.
	HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis.

microbiome->used by->statistical technique:
	Brain-gut microbiota multimodal predictive model in patients with bipolar depression.
	Disrupted diurnal oscillations of the gut microbiota in patients with alcohol dependence.
	Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder.
	Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
	Trends and hotspots on the relationship between gut microbiota and Parkinson's Disease: a bibliometric analysis.
	Correlation between dietary factors and Parkinson's disease revealed by the analysis of Mendelian randomization.
	Correlation between dietary factors and Parkinson's disease revealed by the analysis of Mendelian randomization.
	Meta-analysis of shotgun sequencing of gut microbiota in Parkinson's disease.
	Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.
	Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.

anatomical location->used by->biomedical technique:
	Human microbiota from drug-naive patients with obsessive-compulsive disorder drives behavioral symptoms and neuroinflammation via succinic acid in mice.
	Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
	Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization.
	Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization.
	Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization.
	Microbial Therapeutics in Neurocognitive and Psychiatric Disorders.
	An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats.
	An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats.
	An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats.
	An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats.
	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
	The gut microbiota influences skeletal muscle mass and function in mice.
	The gut microbiota influences skeletal muscle mass and function in mice.
	Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
	Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
	Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
	Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
	Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
	Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
	Multi-Strain Probiotic Mixture Affects Brain Morphology and Resting State Brain Function in Healthy Subjects: An RCT.
	Multi-Strain Probiotic Mixture Affects Brain Morphology and Resting State Brain Function in Healthy Subjects: An RCT.
	Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
	Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
	Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
	Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
	Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota.
	Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota.
	Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota.
	Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota.
	Gut microbiota from patients with Parkinson's disease causes motor deficits in honeybees.
	Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.

drug->located in->animal:
	Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
	Ginsenoside Rh4 remodels the periphery microenvironment by targeting the brain-gut axis to alleviate depression-like behaviors.
	Ginsenoside Rh4 remodels the periphery microenvironment by targeting the brain-gut axis to alleviate depression-like behaviors.
	Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment.

drug->change effect->drug:
	Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
	Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut-microbiota-brain axis.
	A novel pathway of levodopa metabolism by commensal Bifidobacteria.

chemical->is linked to->DDF:
	Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
	Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
	Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.
	Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
	Role of Microbiota-Modified Bile Acids in the Regulation of Intracellular Organelles and Neurodegenerative Diseases.
	Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review.
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).

bacteria->influence->chemical:
	Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling.
	A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.

chemical->influence->anatomical location:
	The Gut and Parkinson's Disease-A Bidirectional Pathway.
	The Gut and Parkinson's Disease-A Bidirectional Pathway.
	The Gut and Parkinson's Disease-A Bidirectional Pathway.
	The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
	The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
	The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
	Gastrointestinal dysmotility in rodent models of Parkinson's disease.
	Gastrointestinal dysmotility in rodent models of Parkinson's disease.

microbiome->affect->DDF:
	Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
	Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders.
	A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.
	The effects of microbiota abundance on symptom severity in Parkinson's disease: A systematic review.
	Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
	Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota.
	Gut-first Parkinson's disease is encoded by gut dysbiome.
	From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases.

microbiome->influence->DDF:
	The relationship between sleep, gut microbiota, and metabolome in patients with depression and anxiety: A secondary analysis of the observational study.
	The relationship between sleep, gut microbiota, and metabolome in patients with depression and anxiety: A secondary analysis of the observational study.
	Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A <i>Post Hoc</i> Analysis of a Randomized Clinical Trial.
	Gut microbes influence the development of central nervous system disorders through epigenetic inheritance.
	Gut microbes influence the development of central nervous system disorders through epigenetic inheritance.
	Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies.
	Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies.
	Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in mice.
	The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder.
	Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.
	Mapping trends and hotspot regarding gastrointestinal microbiome and neuroscience: A bibliometric analysis of global research (2002-2022).
	Bacterial Metabolites of Human Gut Microbiota Correlating with Depression.
	Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons.
	Modulating the Gut Microbiota as a Therapeutic Intervention for Alzheimer's Disease.
	The gut microbiota-brain axis in neurological disorder.
	Does gut brain axis has an impact on Parkinson's disease (PD)?
	The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
	Relationship Between Short-chain Fatty Acids and Parkinson's Disease: A Review from Pathology to Clinic.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut-first Parkinson's disease is encoded by gut dysbiome.
	The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson's disease.
	From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases.

microbiome->impact->microbiome:
	The relationship between sleep, gut microbiota, and metabolome in patients with depression and anxiety: A secondary analysis of the observational study.
	Relationship Between Short-chain Fatty Acids and Parkinson's Disease: A Review from Pathology to Clinic.

microbiome->is linked to->chemical:
	Combined oral contraceptives and mental health: Are adolescence and the gut-brain axis the missing links?
	Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A <i>Post Hoc</i> Analysis of a Randomized Clinical Trial.
	Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
	The Microbiome-Mitochondria Dance in Prodromal Parkinson's Disease.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.

microbiome->is linked to->drug:
	Gut Microbiota Changes in Patients with Bipolar Depression.
	Effects of antipsychotics on the gastrointestinal microbiota: A systematic review.
	Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.
	Effects of molecular hydrogen intervention on the gut microbiome in methamphetamine abusers with mental disorder.
	Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.
	The interplay between microbiota and brain-gut axis in epilepsy treatment.

human->used by->gene:
	Gut Microbiota Changes in Patients with Bipolar Depression.

DDF->impact->bacteria:
	Priming of microglia with dysfunctional gut microbiota impairs hippocampal neurogenesis and fosters stress vulnerability of mice.

animal->used by->biomedical technique:
	Priming of microglia with dysfunctional gut microbiota impairs hippocampal neurogenesis and fosters stress vulnerability of mice.
	Gut dysbiosis associated with the rats' responses in methamphetamine-induced conditioned place preference.
	Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.
	Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain.
	Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain.
	Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain.
	MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
	Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats.
	Sleep deprivation-induced anxiety-like behaviors are associated with alterations in the gut microbiota and metabolites.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
	Abnormal composition of gut microbiota contributes to delirium-like behaviors after abdominal surgery in mice.
	Serotonin Transporter (SERT) Expression Modulates the Composition of the Western-Diet-Induced Microbiota in Aged Female Mice.
	Abnormalities of the composition of the gut microbiota and short-chain fatty acids in mice after splenectomy.
	Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson's Disease Rats.
	Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice.
	Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice.
	Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice.
	Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice.
	The gut microbiota influences skeletal muscle mass and function in mice.
	Heat-killed Enterococcus fecalis (EC-12) supplement alters the expression of neurotransmitter receptor genes in the prefrontal cortex and alleviates anxiety-like behavior in mice.
	Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice.
	Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place Preference.
	Investigation of memory-enhancing effects of Streptococcus thermophilus EG007 in mice and elucidating molecular and metagenomic characteristics using nanopore sequencing.
	Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
	Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
	Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
	Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
	Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
	Oral pathogens exacerbate Parkinson's disease by promoting Th1 cell infiltration in mice.
	Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
	<i>Acanthopanax senticosus</i> Harms improves Parkinson's disease by regulating gut microbial structure and metabolic disorders.
	<i>Acanthopanax senticosus</i> Harms improves Parkinson's disease by regulating gut microbial structure and metabolic disorders.
	<i>Acanthopanax senticosus</i> Harms improves Parkinson's disease by regulating gut microbial structure and metabolic disorders.
	Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent.
	Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent.
	Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent.
	The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
	N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
	Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson's disease after dietary supplementation with branched-chain amino acids.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
	Melatonin mitigates manganese-induced neural damage via modulation of gut microbiota-metabolism in mice.
	Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.
	Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
	Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
	Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
	A role of gut-microbiota-brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice.
	A role of gut-microbiota-brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice.
	A fiber-deprived diet causes cognitive impairment and hippocampal microglia-mediated synaptic loss through the gut microbiota and metabolites.
	Repeated Social Defeat Stress Induces an Inflammatory Gut Milieu by Altering the Mucosal Barrier Integrity and Gut Microbiota Homeostasis.
	Repeated Social Defeat Stress Induces an Inflammatory Gut Milieu by Altering the Mucosal Barrier Integrity and Gut Microbiota Homeostasis.
	Fermented Wheat Germ Alleviates Depression-like Behavior in Rats with Chronic and Unpredictable Mild Stress.
	Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease.
	Exopolysaccharide is the potential effector of <i>Lactobacillus fermentum</i> PS150, a hypnotic psychobiotic strain.
	A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice.
	Sex-specific effects of voluntary wheel running on behavior and the gut microbiota-immune-brain axis in mice.
	Microbial composition, functionality, and stress resilience or susceptibility: unraveling sex-specific patterns.
	Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease.
	Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease.
	Gut Microbiota Dynamics in Parkinsonian Mice.
	Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
	Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota.
	Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota.
	Dcf1 deletion presents alterations in gut microbiota of mice similar to Parkinson's disease.
	Dcf1 deletion presents alterations in gut microbiota of mice similar to Parkinson's disease.
	Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation.
	Characterization of Gut Microbiota in Rats and Rhesus Monkeys After Methamphetamine Self-administration.
	Characterization of Gut Microbiota in Rats and Rhesus Monkeys After Methamphetamine Self-administration.
	Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
	Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
	Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
	Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
	Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
	Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
	Effects of spleen nerve denervation on depression-like phenotype, systemic inflammation, and abnormal composition of gut microbiota in mice after administration of lipopolysaccharide: A role of brain-spleen axis.
	Effects of spleen nerve denervation on depression-like phenotype, systemic inflammation, and abnormal composition of gut microbiota in mice after administration of lipopolysaccharide: A role of brain-spleen axis.
	Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic.
	Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.
	Is anxiety and depression transmissible? Depressed mother rats transmit anxiety- and depression-like phenotypes to cohabited rat pups through gut microbiota assimilation.
	Is anxiety and depression transmissible? Depressed mother rats transmit anxiety- and depression-like phenotypes to cohabited rat pups through gut microbiota assimilation.
	Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease.
	Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease.
	Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Comparison of the chronic unpredictable mild stress and the maternal separation in mice postpartum depression modeling.
	Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
	The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS Autoimmunity.
	The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS Autoimmunity.
	Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
	Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
	Stress and the gut-brain axis: an inflammatory perspective.
	Stress and the gut-brain axis: an inflammatory perspective.
	EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease.
	Supplementation with <i>Lactobacillus helveticus</i> NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression.
	Supplementation with <i>Lactobacillus helveticus</i> NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
	Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon.
	Low-frequency Transcranial Magnetic Stimulation Ameliorates Anhedonic Behaviors and Regulates the Gut Microbiome in Mice Exposed to Chronic Unpredictable Mild Stress.
	The gut in Parkinson's disease: Bottom-up, top-down, or neither?
	The gut in Parkinson's disease: Bottom-up, top-down, or neither?
	Microbiota alterations in proline metabolism impact depression.
	Microbiota alterations in proline metabolism impact depression.
	Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease.
	Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease.
	Network Pharmacology and Absolute Bacterial Quantification-Combined Approach to Explore the Mechanism of Tianqi Pingchan Granule Against 6-OHDA-Induced Parkinson's Disease in Rats.
	Network Pharmacology and Absolute Bacterial Quantification-Combined Approach to Explore the Mechanism of Tianqi Pingchan Granule Against 6-OHDA-Induced Parkinson's Disease in Rats.
	Network Pharmacology and Absolute Bacterial Quantification-Combined Approach to Explore the Mechanism of Tianqi Pingchan Granule Against 6-OHDA-Induced Parkinson's Disease in Rats.
	Metformin reprograms tryptophan metabolism via gut microbiome-derived bile acid metabolites to ameliorate depression-Like behaviors in mice.
	Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
	Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
	Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
	Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
	Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
	Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis.
	Prebiotic Lactulose Ameliorates the Cognitive Deficit in Alzheimer's Disease Mouse Model through Macroautophagy and Chaperone-Mediated Autophagy Pathways.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	The Effect of Long-Term Moderate Static Magnetic Field Exposure on Adult Female Mice.
	Neferine alleviates chronic stress-induced depression by regulating monoamine neurotransmitter secretion and gut microbiota structure.

DDF->impact->microbiome:
	Priming of microglia with dysfunctional gut microbiota impairs hippocampal neurogenesis and fosters stress vulnerability of mice.
	Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats.
	Long-Term Impact of Childhood Adversity on the Gut Microbiome of Nursing Students.
	The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications.

bacteria->administered->human:
	Health Benefits of <i>Lactobacillus gasseri</i> CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study.

dietary supplement->influence->drug:
	Health Benefits of <i>Lactobacillus gasseri</i> CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study.
	Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The "Gut Feelings" randomised controlled trial.
	Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication.

bacteria->influence->drug:
	Health Benefits of <i>Lactobacillus gasseri</i> CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study.

chemical->impact->anatomical location:
	Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain.
	Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice.
	Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice.

dietary supplement->affect->DDF:
	Sex difference in prebiotics on gut and blood-brain barrier dysfunction underlying stress-induced anxiety and depression.
	Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
	Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
	The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.
	The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.
	The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.
	The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.
	The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.
	Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.
	Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.

microbiome->used by->dietary supplement:
	Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review.
	A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation.

microbiome->target->human:
	Altered gut microbiota profile in patients with perimenopausal panic disorder.
	The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice.
	Altered fecal microbiota composition in individuals who abuse methamphetamine.
	Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
	Could the Urease of the Gut Bacterium <i>Proteus mirabilis</i> Play a Role in the Altered Gut-Brain Talk Associated with Parkinson's Disease?

DDF->affect->anatomical location:
	New Pieces for an Old Puzzle: Approaching Parkinson's Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics.
	New Pieces for an Old Puzzle: Approaching Parkinson's Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics.

gene->used by->biomedical technique:
	Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization.

animal->used by->statistical technique:
	Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain.
	Abnormal composition of gut microbiota contributes to delirium-like behaviors after abdominal surgery in mice.

microbiome->is linked to->animal:
	Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.
	5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota.
	Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice.

drug->affect->DDF:
	Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop-The Modulating Role of <i>Anacyclus pyrethrum</i>.
	Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop-The Modulating Role of <i>Anacyclus pyrethrum</i>.
	Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop-The Modulating Role of <i>Anacyclus pyrethrum</i>.
	Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop-The Modulating Role of <i>Anacyclus pyrethrum</i>.
	Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop-The Modulating Role of <i>Anacyclus pyrethrum</i>.
	Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner.
	Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner.
	Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner.
	Ginsenoside Rh4 remodels the periphery microenvironment by targeting the brain-gut axis to alleviate depression-like behaviors.
	Arketamine for cognitive impairment in psychiatric disorders.
	Effects of molecular hydrogen intervention on the gut microbiome in methamphetamine abusers with mental disorder.
	Acupuncture for Parkinson's disease-related constipation: current evidence and perspectives.
	Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease.

microbiome->is linked to->biomedical technique:
	Therapies for Parkinson's disease and the gut microbiome: evidence for bidirectional connection.
	Therapies for Parkinson's disease and the gut microbiome: evidence for bidirectional connection.
	Therapies for Parkinson's disease and the gut microbiome: evidence for bidirectional connection.
	Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment.
	Gut Microbes and Neuropathology: Is There a Causal Nexus?
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
	Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.

anatomical location->is linked to->DDF:
	The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review.
	Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders.
	Impact of intestinal disorders on central and peripheral nervous system diseases.
	The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
	Maternal Obesity as a Risk Factor for Brain Development and Mental Health in the Offspring.
	Maternal Obesity as a Risk Factor for Brain Development and Mental Health in the Offspring.
	Unraveling the gut-brain connection: The association of microbiota-linked structural brain biomarkers with behavior and mental health.
	Unraveling the gut-brain connection: The association of microbiota-linked structural brain biomarkers with behavior and mental health.
	Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
	Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
	Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis.
	Gut-oriented disease modifying therapy for Parkinson's disease.
	Gut-oriented disease modifying therapy for Parkinson's disease.
	Microbiota Dysbiosis in Parkinson Disease-In Search of a Biomarker.
	Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging-A Review.
	From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?
	Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
	Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.
	Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.
	Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.
	Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.
	Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.
	Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson's Disease: A Review of Inflammatory Markers and Potential Effects.
	Intestinal Barrier Function and Neurodegenerative Disease.
	Intestinal Barrier Function and Neurodegenerative Disease.
	Gastrointestinal dysmotility in rodent models of Parkinson's disease.
	Gastrointestinal dysmotility in rodent models of Parkinson's disease.
	From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases.

microbiome->is linked to->statistical technique:
	Association between gut microbiota and hepatocellular carcinoma from 2011 to 2022: Bibliometric analysis and global trends.
	Trends and hotspots on the relationship between gut microbiota and Parkinson's Disease: a bibliometric analysis.
	Unravelling the mechanisms of underweight in Parkinson's disease by investigating into the role of gut microbiome.

gene->influence->DDF:
	PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
	PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
	PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
	MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
	Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
	Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
	Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
	Maternal exposure of mice to glyphosate induces depression- and anxiety-like behavior in the offspring via alterations of the gut-brain axis.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
	Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
	Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration.
	The Brain-Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review.
	The Brain-Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review.
	The Brain-Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review.
	The Brain-Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review.
	The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson's disease.
	The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases.
	Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.
	Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.

gene->impact->microbiome:
	PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
	Serotonin Transporter (SERT) Expression Modulates the Composition of the Western-Diet-Induced Microbiota in Aged Female Mice.
	Serotonin Transporter (SERT) Expression Modulates the Composition of the Western-Diet-Induced Microbiota in Aged Female Mice.
	Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association.
	The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson's disease.

chemical->used by->biomedical technique:
	Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).

drug->target->human:
	Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
	Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial.
	Altered fecal microbiota composition in individuals who abuse methamphetamine.
	Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease.

biomedical technique->is linked to->DDF:
	Exploring the interplay between posttraumatic stress disorder, gut microbiota, and inflammatory biomarkers: a comprehensive meta-analysis.

biomedical technique->affect->DDF:
	Are neuromodulation interventions associated with changes in the gut microbiota? A systematic review.
	Are neuromodulation interventions associated with changes in the gut microbiota? A systematic review.
	Are neuromodulation interventions associated with changes in the gut microbiota? A systematic review.
	Are neuromodulation interventions associated with changes in the gut microbiota? A systematic review.
	Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
	The Neuroprotective Effects of Electroacupuncture on Parkinson's Disease and the Underlying Molecular Mechanisms.

microbiome->is linked to->anatomical location:
	Gut microbes influence the development of central nervous system disorders through epigenetic inheritance.
	Gut microbes influence the development of central nervous system disorders through epigenetic inheritance.
	Altered fecal microbiota composition in individuals who abuse methamphetamine.

gene->located in->anatomical location:
	MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
	The gut microbiota influences skeletal muscle mass and function in mice.
	The gut microbiota influences skeletal muscle mass and function in mice.
	Impact of broad-spectrum antibiotics on the gut-microbiota-spleen-brain axis.
	Neuroprotective Effects of <i>Lactobacillus plantarum</i> PS128 in a Mouse Model of Parkinson's Disease: The Role of Gut Microbiota and MicroRNAs.
	Neuroprotective Effects of <i>Lactobacillus plantarum</i> PS128 in a Mouse Model of Parkinson's Disease: The Role of Gut Microbiota and MicroRNAs.
	Neuroprotective Effects of <i>Lactobacillus plantarum</i> PS128 in a Mouse Model of Parkinson's Disease: The Role of Gut Microbiota and MicroRNAs.

drug->influence->drug:
	Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression.
	Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression.

gene->interact->chemical:
	Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice.
	Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice.

chemical->strike->anatomical location:
	Metaorganismal choline metabolism shapes olfactory perception.
	What the Gut Tells the Brain-Is There a Link between Microbiota and Huntington's Disease?

microbiome->is linked to->human:
	Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China.
	Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
	Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease.

chemical->influence->chemical:
	Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
	Ginsenoside Rk3 Regulates Tryptophan Metabolism along the Brain-Gut Axis by Targeting Tryptophan Hydroxylase and Remodeling the Intestinal Microenvironment to Alleviate Depressive-Like Behavior in Mice.
	The progress of gut microbiome research related to brain disorders.
	Demonstrating a link between diet, gut microbiota and brain: <sup>14</sup>C radioactivity identified in the brain following gut microbial fermentation of <sup>14</sup>C-radiolabeled tyrosine in a pig model.
	Intermittent fasting protects against Alzheimer's disease in mice by altering metabolism through remodeling of the gut microbiota.
	Bacterial Extracellular Vesicles and the Gut-Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics.
	Causal effect of gut-microbiota-derived metabolite trimethylamine N-oxide on Parkinson's disease: A Mendelian randomization study.
	Urolithin A in Health and Diseases: Prospects for Parkinson's Disease Management.
	Urolithin A in Health and Diseases: Prospects for Parkinson's Disease Management.
	Diet-gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders.
	Diet-gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders.
	Diet-gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders.
	Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson's disease.
	Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice.
	Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview.

bacteria->located in->microbiome:
	Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.

animal->located in->animal:
	Abnormal composition of gut microbiota contributes to delirium-like behaviors after abdominal surgery in mice.

bacteria->located in->anatomical location:
	Psychobiotics, gut microbiota and fermented foods can help preserving mental health.
	Unraveling the gut-brain connection: The association of microbiota-linked structural brain biomarkers with behavior and mental health.
	Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
	Gut Microbiota as a Mediator of Host Neuro-Immune Interactions: Implications in Neuroinflammatory Disorders.
	The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications.
	Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
	Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
	The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases.
	The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases.
	<i>Akkermansia muciniphila</i> Is Beneficial to a Mouse Model of Parkinson's Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs.

microbiome->used by->drug:
	Effects of antipsychotics on the gastrointestinal microbiota: A systematic review.
	Infections, antibiotic treatment and the Microbiome in relation to schizophrenia.

drug->change effect->human:
	Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia.

chemical->target->animal:
	The role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in chronic inflammatory pain and comorbid spatial working memory impairment in complete Freund's adjuvant mice.
	The role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in chronic inflammatory pain and comorbid spatial working memory impairment in complete Freund's adjuvant mice.
	Intermittent fasting protects against Alzheimer's disease in mice by altering metabolism through remodeling of the gut microbiota.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.

drug->target->animal:
	The role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in chronic inflammatory pain and comorbid spatial working memory impairment in complete Freund's adjuvant mice.
	Role of the gut-brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress.

chemical->influence->microbiome:
	Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain axis.
	Neuroprotective effects of an engineered <i>Escherichia coli</i> Nissle 1917 on Parkinson's disease in mice by delivering GLP-1 and modulating gut microbiota.
	Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota.
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.
	Toxic Metals Impact Gut Microbiota and Metabolic Risk in Five African-Origin Populations.

animal->used by->DDF:
	Komagataella pastoris KM71H Mitigates Depressive-Like Phenotype, Preserving Intestinal Barrier Integrity and Modulating the Gut Microbiota in Mice.

bacteria->influence->animal:
	A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.
	<i>Lactobacillus plantarum</i> CCFM405 against Rotenone-Induced Parkinson's Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis.

chemical->influence->animal:
	A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.
	A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.
	5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota.

bacteria->is linked to->DDF:
	Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
	Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases.
	Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases.
	Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases.
	Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases.
	Hypothesizing mechanistic links between microbes and disease using knowledge graphs.
	Hypothesizing mechanistic links between microbes and disease using knowledge graphs.
	Hypothesizing mechanistic links between microbes and disease using knowledge graphs.
	The role of gut microbiota in the pathogenesis and treatment of postpartum depression.
	The role of gut microbiota in the pathogenesis and treatment of postpartum depression.
	Current and further outlook on the protective potential of <i>Antrodia camphorata</i> against neurological disorders.
	Potential Role of Akkermansia muciniphila in Parkinson's Disease and Other Neurological/Autoimmune Diseases.
	Potential Role of Akkermansia muciniphila in Parkinson's Disease and Other Neurological/Autoimmune Diseases.
	Infectious Microorganisms Seen as Etiologic Agents in Parkinson's Disease.
	Could the Urease of the Gut Bacterium <i>Proteus mirabilis</i> Play a Role in the Altered Gut-Brain Talk Associated with Parkinson's Disease?
	Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats.

biomedical technique->influence->DDF:
	The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation.
	Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial.
	Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis.
	Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats.
	Electroacupuncture blocked motor dysfunction and gut barrier damage by modulating intestinal NLRP3 inflammasome in MPTP-induced Parkinson's disease mice.
	Electroacupuncture blocked motor dysfunction and gut barrier damage by modulating intestinal NLRP3 inflammasome in MPTP-induced Parkinson's disease mice.

human->change abundance->bacteria:
	Disrupted diurnal oscillations of the gut microbiota in patients with alcohol dependence.
	Alterations in the intestinal microbiome and mental health status of workers in an underground tunnel environment.
	Associations among diet, the gastrointestinal microbiota, and negative emotional states in adults.
	Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls.
	Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls.

human->change abundance->microbiome:
	Disrupted diurnal oscillations of the gut microbiota in patients with alcohol dependence.
	An exploratory study of the gut microbiota in major depression with anxious distress.

DDF->affect->chemical:
	COVID-19: The Significance of Platelets, Mitochondria, Vitamin D, Serotonin and the Gut Microbiota.

DDF->influence->dietary supplement:
	Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks.
	Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks.

bacteria->produced by->microbiome:
	Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model.
	Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model.

chemical->produced by->anatomical location:
	Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model.

animal->produced by->microbiome:
	Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model.

biomedical technique->target->human:
	Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.
	Gut microbiota of Parkinson's disease in an appendectomy cohort: a preliminary study.
	Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
	The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial.
	Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's disease: results from an open label single-arm study.
	Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's disease: results from an open label single-arm study.

drug->influence->chemical:
	Rifaximin modulates TRH and TRH-like peptide expression throughout the brain and peripheral tissues of male rats.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.

dietary supplement->is linked to->DDF:
	Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases.

anatomical location->target->human:
	Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial.

DDF->target->anatomical location:
	Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial.

gene->influence->chemical:
	Gut microbiota-mediated ursodeoxycholic acids regulate the inflammation of microglia through TGR5 signaling after MCAO.

chemical->located in->microbiome:
	Roles of Diet-Associated Gut Microbial Metabolites on Brain Health: Cell-to-Cell Interactions between Gut Bacteria and the Central Nervous System.

DDF->change effect->DDF:
	Association between gut microbiota dysbiosis and poor functional outcomes in acute ischemic stroke patients with COVID-19 infection.

drug->impact->animal:
	Effects of therapeutic levels of dietary antibiotics on the cecal microbiome composition of broiler chickens.
	Effects of therapeutic levels of dietary antibiotics on the cecal microbiome composition of broiler chickens.
	Effects of therapeutic levels of dietary antibiotics on the cecal microbiome composition of broiler chickens.

DDF->change abundance->gene:
	Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.
	Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.
	Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.
	Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.
	Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.

chemical->affect->DDF:
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases.
	Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
	Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
	Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
	Bacterial Extracellular Vesicles and the Gut-Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics.
	Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
	Causal effect of gut-microbiota-derived metabolite trimethylamine N-oxide on Parkinson's disease: A Mendelian randomization study.
	Causal effect of gut-microbiota-derived metabolite trimethylamine N-oxide on Parkinson's disease: A Mendelian randomization study.
	Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
	Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
	Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
	Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
	Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota.
	Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota.
	Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota.
	Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota.
	Could the Urease of the Gut Bacterium <i>Proteus mirabilis</i> Play a Role in the Altered Gut-Brain Talk Associated with Parkinson's Disease?
	Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson's Disease.
	Fecal microbiome transplantation alleviates manganese-induced neurotoxicity by altering the composition and function of the gut microbiota via the cGAS-STING/NLRP3 pathway.
	Fecal microbiome transplantation alleviates manganese-induced neurotoxicity by altering the composition and function of the gut microbiota via the cGAS-STING/NLRP3 pathway.
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
	Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).

bacteria->change effect->DDF:
	Heat-killed Enterococcus fecalis (EC-12) supplement alters the expression of neurotransmitter receptor genes in the prefrontal cortex and alleviates anxiety-like behavior in mice.

bacteria->used by->biomedical technique:
	Heat-killed Enterococcus fecalis (EC-12) supplement alters the expression of neurotransmitter receptor genes in the prefrontal cortex and alleviates anxiety-like behavior in mice.

bacteria->administered->animal:
	Heat-killed Enterococcus fecalis (EC-12) supplement alters the expression of neurotransmitter receptor genes in the prefrontal cortex and alleviates anxiety-like behavior in mice.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.

DDF->is linked to->DDF:
	Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.
	Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention.
	Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention.
	Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention.
	Current Perspectives on Gut Microbiome Dysbiosis and Depression.
	Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
	The impact of Parkinson's disease-associated gut microbiota on the transcriptome in <i>Drosophila</i>.
	Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
	Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice.
	Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice.
	Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice.
	Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice.
	Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease: Indication from Gut Microbiota Alterations.
	Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease: Indication from Gut Microbiota Alterations.
	Gut microbiota in neurological diseases: Melatonin plays an important regulatory role.
	Gut microbiota in neurological diseases: Melatonin plays an important regulatory role.
	Psychobiotic Properties of <i>Lactiplantibacillus plantarum</i> in Neurodegenerative Diseases.
	Implications of Butyrate Signaling Pathways on the Motor Symptomatology of Parkinson's Disease and Neuroprotective Effects-Therapeutic Approaches: A Systematic Review.
	Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications.
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.

DDF->target->microbiome:
	Impact of probiotic on anxiety and depression symptoms in pregnant and lactating women and microbiota of infants: A systematic review and meta-analysis.

bacteria->target->human:
	Characteristics of the Gut Microbiome and Serum Metabolome in Patients with Functional Constipation.

human->influence->DDF:
	Constipation and Cigarette Smoking Are Independent Influences for Parkinson's Disease.
	Constipation and Cigarette Smoking Are Independent Influences for Parkinson's Disease.
	Should Pregnant Women Consume Probiotics to Combat Endocrine-Disrupting Chemical-Induced Health Risks to Their Unborn Offspring?

dietary supplement->influence->microbiome:
	Impending Mental Health Issues During Coronavirus Disease 2019 - Time for Personalized Nutrition Based on the Gut Microbiota to Tide Over the Crisis?
	Personalized Response of Parkinson's Disease Gut Microbiota to Nootropic Medicinal Herbs In Vitro: A Proof of Concept.

chemical->target->human:
	The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial.

human->used by->human:
	Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease.

bacteria->is linked to->biomedical technique:
	Current and further outlook on the protective potential of <i>Antrodia camphorata</i> against neurological disorders.

DDF->located in->human:
	Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.

dietary supplement->influence->chemical:
	Probiotics supplementation and brain-derived neurotrophic factor (BDNF): a systematic review and meta-analysis of randomized controlled trials.
	Curcumin Alleviates DSS-Induced Anxiety-Like Behaviors via the Microbial-Brain-Gut Axis.
	Exploration of the Gut-Brain Axis through Metabolomics Identifies Serum Propionic Acid Associated with Higher Cognitive Decline in Older Persons.
	Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
	<i>Lactobacillus plantarum</i> CCFM405 against Rotenone-Induced Parkinson's Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.

dietary supplement->target->human:
	The Effect of Probiotic Supplementation on the Gut-Brain Axis in Psychiatric Patients.

drug->influence->microbiome:
	Psychedelics as a novel approach to treating autoimmune conditions.

gene->influence->microbiome:
	Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.

statistical technique->affect->DDF:
	Associations Between the Gut Microbiota and Internalizing Behaviors in Preschool Children.
	Associations Between the Gut Microbiota and Internalizing Behaviors in Preschool Children.

animal->used by->animal:
	Intermittent fasting protects against Alzheimer's disease in mice by altering metabolism through remodeling of the gut microbiota.

chemical->influence->gene:
	Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice.
	Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway.
	Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway.

DDF->strike->microbiome:
	Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice.

microbiome->used by->chemical:
	Investigation of memory-enhancing effects of Streptococcus thermophilus EG007 in mice and elucidating molecular and metagenomic characteristics using nanopore sequencing.

food->influence->chemical:
	Exploration of the Gut-Brain Axis through Metabolomics Identifies Serum Propionic Acid Associated with Higher Cognitive Decline in Older Persons.

chemical->change abundance->microbiome:
	Should Pregnant Women Consume Probiotics to Combat Endocrine-Disrupting Chemical-Induced Health Risks to Their Unborn Offspring?
	Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study.

dietary supplement->influence->human:
	Should Pregnant Women Consume Probiotics to Combat Endocrine-Disrupting Chemical-Induced Health Risks to Their Unborn Offspring?

bacteria->affect->DDF:
	Parkinson's Disease and Gut Microbiota.
	Oral pathogens exacerbate Parkinson's disease by promoting Th1 cell infiltration in mice.

microbiome->impact->bacteria:
	The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review.

drug->produced by->microbiome:
	Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-<i>κ</i>B pathway through microbiota-gut-brain axis.
	Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment.

DDF->affect->drug:
	Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment.

chemical->impact->chemical:
	Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease.
	<i>Gastrodia elata</i> polysaccharide alleviates Parkinson's disease <i>via</i> inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota.
	Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview.

food->located in->anatomical location:
	Diet, Gut Microbiome, and Cognitive Decline.

drug->change effect->chemical:
	Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.

DDF->change abundance->anatomical location:
	Role of the Gut-Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson's Disease.
	Gastrointestinal disorders in Parkinson's disease and other Lewy body diseases.

anatomical location->influence->DDF:
	Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
	Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
	Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.

dietary supplement->influence->animal:
	Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids.
	Rosmarinic acid mitigates intestinal inflammation and oxidative stress in bullfrogs (Lithobates catesbeiana) fed high soybean meal diets.

DDF->strike->bacteria:
	The link between the gut microbiome, inflammation, and Parkinson's disease.
	The link between the gut microbiome, inflammation, and Parkinson's disease.

chemical->located in->bacteria:
	The link between the gut microbiome, inflammation, and Parkinson's disease.

anatomical location->affect->DDF:
	The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications.
	The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications.

bacteria->impact->bacteria:
	<i>Lactobacillus plantarum</i> CCFM405 against Rotenone-Induced Parkinson's Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis.

microbiome->target->animal:
	The impact of Parkinson's disease-associated gut microbiota on the transcriptome in <i>Drosophila</i>.
	Neuroprotective effect of engineered <i>Clostridium</i>butyricum-pMTL007-GLP-1 on Parkinson's disease mice models via promoting mitophagy.

bacteria->impact->microbiome:
	Effect of <i>Lacticaseibacillus paracasei</i> strain Shirota supplementation on clinical responses and gut microbiome in Parkinson's disease.
	Effect of <i>Lacticaseibacillus paracasei</i> strain Shirota supplementation on clinical responses and gut microbiome in Parkinson's disease.
	Effect of <i>BF</i>839 + earthworm protein supplement on motor and some non-motor symptoms of Parkinson's disease: a randomized clinical trial.

anatomical location->target->animal:
	Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.

dietary supplement->produced by->microbiome:
	Unveiling the neuroprotective potential of dietary polysaccharides: a systematic review.

microbiome->produced by->microbiome:
	Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis.

microbiome->used by->DDF:
	Fecal Microbiota Transplantation from Aged Mice Render Recipient Mice Resistant to MPTP-Induced Nigrostriatal Degeneration Via a Neurogenesis-Dependent but Inflammation-Independent Manner.

animal->target->animal:
	Fecal Microbiota Transplantation from Aged Mice Render Recipient Mice Resistant to MPTP-Induced Nigrostriatal Degeneration Via a Neurogenesis-Dependent but Inflammation-Independent Manner.

chemical->is linked to->microbiome:
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.

dietary supplement->influence->bacteria:
	The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications.
	The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications.

animal->used by->chemical:
	Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.

microbiome->is linked to->food:
	Correlation between dietary factors and Parkinson's disease revealed by the analysis of Mendelian randomization.

dietary supplement->impact->anatomical location:
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.

dietary supplement->interact->chemical:
	A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.

drug->impact->chemical:
	Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.

DDF->is a->human:
	Bidirectional communication of the gut-brain axis: new findings in Parkinson's disease and inflammatory bowel disease.

DDF->target->DDF:
	Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.
	Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.
	Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.
	Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.
	Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
	Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
	Comparative analysis of gut microbiota in major depressive disorder and schizophrenia during hospitalisation - the case-control, post hoc study.
	Comparative analysis of gut microbiota in major depressive disorder and schizophrenia during hospitalisation - the case-control, post hoc study.

biomedical technique->influence->chemical:
	Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats.

bacteria->is linked to->bacteria:
	Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats.

biomedical technique->change effect->DDF:
	Electroacupuncture blocked motor dysfunction and gut barrier damage by modulating intestinal NLRP3 inflammasome in MPTP-induced Parkinson's disease mice.

biomedical technique->administered->animal:
	Melatonin mitigates manganese-induced neural damage via modulation of gut microbiota-metabolism in mice.

food->change effect->DDF:
	The role of gut-derived short-chain fatty acids in Parkinson's disease.

dietary supplement->impact->DDF:
	Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.

dietary supplement->target->animal:
	Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.

human->used by->drug:
	Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals.

anatomical location->located in->anatomical location:
	Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications.
	Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications.

chemical->is linked to->bacteria:
	Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.

biomedical technique->target->animal:
	Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress.

microbiome->located in->DDF:
	Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
	Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.

